Evidence map›Paper›PMID 36364888›Full record

ArticleNutrients2022

Evaluation of the Effects of the Tritordeum-Based Diet Compared to the Low-FODMAPs Diet on the Fecal Metabolome of IBS-D Patients: A Preliminary Investigation.

Giusy Rita Caponio, Giuseppe Celano, Francesco Maria Calabrese, Giuseppe Riezzo, Antonella Orlando, Benedetta D'Attoma, Antonia Ignazzi, Mirco Vacca, Annalisa Porrelli, Valeria Tutino and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06618677 (Efficacy of a Low FODMAP Diet in IBS Children and Impact on Microbiota, Urinary and Faecal Metabolome), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06618677 nacompletednot on this mapstarted 2023, after this paper: background citation

Efficacy of a Low FODMAP Diet in IBS Children and Impact on Microbiota, Urinary and Faecal Metabolome

TypeinterventionalSponsorUniversity of BariRan2023 to 2024Enrolled70ConditionsIBS, Functional Gastrointestinal DisordersArmsLOW FODMAPs Diet
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Giusy Rita CaponioNational Institute of Gastroenterology "S. de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.ORCID 0000-0001-5446-5776
Giuseppe CelanoDepartment of Soil, Plant and Food Science, University of Bari Aldo Moro, 70126 Bari, Italy.ORCID 0000-0002-3805-7681
Francesco Maria CalabreseDepartment of Soil, Plant and Food Science, University of Bari Aldo Moro, 70126 Bari, Italy.ORCID 0000-0003-0176-7046
Giuseppe RiezzoNational Institute of Gastroenterology "S. de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.
Antonella OrlandoNational Institute of Gastroenterology "S. de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.ORCID 0000-0001-8255-4776
Benedetta D'AttomaNational Institute of Gastroenterology "S. de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.
Antonia IgnazziNational Institute of Gastroenterology "S. de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.
Mirco VaccaDepartment of Soil, Plant and Food Science, University of Bari Aldo Moro, 70126 Bari, Italy.ORCID 0000-0003-0813-169X
Annalisa PorrelliDepartment of Soil, Plant and Food Science, University of Bari Aldo Moro, 70126 Bari, Italy.
Valeria TutinoNational Institute of Gastroenterology "S. de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.
Maria De AngelisDepartment of Soil, Plant and Food Science, University of Bari Aldo Moro, 70126 Bari, Italy.ORCID 0000-0002-2010-884X
Gianluigi GiannelliNational Institute of Gastroenterology "S. de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.
Francesco RussoNational Institute of Gastroenterology "S. de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.ORCID 0000-0003-0538-6072
Gastroenterology Hospital "Saverio de Bellis" · ITUniversity of Bari Aldo Moro · IT

Funding

Italian Ministry of Health RC 2020-2021, Prog. N° 16 (DDG n. 700/2020).
6 · The paper itself

Abstract

Since irritable bowel syndrome (IBS)-a common gastrointestinal (GI) disorder-still lacks effective therapy, a nutritional approach may represent a practical alternative. Different reports demonstrated that a low-fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) diet (LFD) reduces symptoms in IBS with diarrhea (IBS-D) patients, also inducing beneficial pathophysiological and biochemical modifications. More recently, diets with alternative cereals having a different gluten composition, such as tritordeum, have also been considered (TBD). We investigated the impact of TBD and LFD on the fecal metabolome composition in 38 IBS-D patients randomly allocated to the two diets for 12 weeks. Summarily, at baseline, the profile of fecal volatile organic compounds (VOCs) of IBS-D patients was not significantly different in the two groups. After treatment, significant changes were observed in the two groups regarding the VOCs content since some of them increased in the TBD group (namely, decanoic acid), whereas others (i.e., nonanal and ethanol) increased in the LFD one. Further, at baseline, short-chain fatty acids were positively related to inflammation and showed a significant decreasing trend after both diets compared to baseline values (namely, acetic and propanoic acid). Preliminary results from this pilot study suggest a potential positive intervention of TBD and LFD affecting the fecal metabolome composition in IBS-D patients.

Indexed as

Irritable Bowel SyndromeMonosaccharidesDietDiet, Carbohydrate-RestrictedDisaccharidesFermentationHumansMetabolomeOligosaccharidesPilot ProjectsDisaccharidesMonosaccharidesOligosaccharidesdietfunctional gastrointestinal disordersirritable bowel syndromemetabolomeshort-chain fatty acidsTritordeumvolatile organic compounds

Identifiers

PMID36364888
PMCPMC9657445
OpenAlexW4309091570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.